The immunogenicity, protective efficacy and safety of BBG2Na, a subunit respiratory syncytial virus (RSV) vaccine candidate, against RSV-B

By Power U.F.   Plotnicky H.   Blaecke A.   Nguyen T.N.  

Vaccine, Vol. 22, Iss. 2, 2003-12 ,pp. : 168-176

Elsevier

Access to resources Recommend Favorite

Influence of live respiratory syncytial virus priming on the immune response generated by a recombinant vaccine candidate, BBG2Na

By Goestch L.   Plotnicky-Gilquin H.   Champion T.   Beck A.   Haeuw J.F.   Nguyen T.   Bonnefoy J.Y.   Corvaa N.  

Vaccine, Vol. 18, Iss. 24, 2000-06 ,pp. : 2648-2655

Elsevier

Access to resources Recommend Favorite

DDA adjuvant induces a mixed Th1/Th2 immune response when associated with BBG2Na, a respiratory syncytial virus potential vaccine

By Klinguer-Hamour C.   Libon C.   Plotnicky-Gilquin H.   Bussat M.-C.   Revy L.   Nguyen T.   Bonnefoy J.-Y.   Corvaa N.   Beck A.  

Vaccine, Vol. 20, Iss. 21, 2002-06 ,pp. : 2743-2751

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in the institutionalized elderly

By Falsey A.R.   Walsh E.E.  

Vaccine, Vol. 15, Iss. 10, 1997-07 ,pp. : 1130-1132

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60

By Falsey A.R.   Walsh E.E.  

Vaccine, Vol. 14, Iss. 13, 1996-09 ,pp. : 1214-1218

Elsevier

Access to resources Recommend Favorite